Ricolinostat (ACY-1215) suppresses proliferation and promotes apoptosis in esophageal squamous cell carcinoma via miR-30d/PI3K/AKT/mTOR and ERK pathways

Ricolinostat (ACY-1215) suppresses proliferation and promotes apoptosis in esophageal squamous cell carcinoma via miR-30d/PI3K/AKT/mTOR and ERK pathwaysRicolinostat (ACY-1215) suppresses proliferation and promotes apoptosis in esophageal squamous cell carcinoma via miR-30d/PI3K/AKT/mTOR and ERK pathways, Published online: 26 July 2018; doi:10.1038/s41419-018-0788-2Ricolinostat (ACY-1215) suppresses proliferation and promotes apoptosis in esophageal squamous cell carcinoma via miR-30d/PI3K/AKT/mTOR and ERK pathways

http://feeds.nature.com/~r/cddis/rss/current/~3/20MiZpFZaH8/s41419-018-0788-2

Source: Cell death and disease - July 26, 2018 Category: Internal Medicine Authors: Jinlin Cao Wang Lv Luming Wang Jinming Xu Ping Yuan Sha Huang Zhehao He Jian Hu Source Type: research